Back to Startup Insights
HeartBeat.bio
HeartBeat.bio is focused on transforming cardiac drug discovery and development using AI-driven platforms.
Headquarters
Vienna, Austria
Year Founded
2021
Founders
Dr. Anna Schmidt
Country
Austria
Financial Information
Funding Stage
Seed
Recent Funding
$4.8 M
Funding By
IST Austria
Core Technology
AI for cardiac drugs
Product Type
Drug
Pipeline Stage (Very Important)
Discovery
Regulatory Status
- IND Filed: No
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Filed
Partnerships
Pharma Collaborations
None
Academic / Hospital Tie-ups
Vienna University
CRO/CDMO Partnerships
None
Market & Differentiation
AI cardiac focus